Kaufmann SH - Search Results

1

Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer.

Ray U, Jung DB, Jin L, Xiao Y, Dasari S, Sarkar Bhattacharya S, Thirusangu P, Staub JK, Roy D, Roy B, Weroha SJ, Hou X, Purcell JW, Bakkum-Gamez JN, Kaufmann SH, Kannan N, Mitra AK, Shridhar V. Ray U, et al. Among authors: kaufmann sh. Cancer Res. 2022 Mar 15;82(6):1038-1054. doi: 10.1158/0008-5472.CAN-21-0622. Cancer Res. 2022. PMID: 34654724 Free PMC article.

2

Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells.

Bible KC, Kaufmann SH. Bible KC, et al. Among authors: kaufmann sh. Cancer Res. 1996 Nov 1;56(21):4856-61. Cancer Res. 1996. PMID: 8895733

3

Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.

Bible KC, Kaufmann SH. Bible KC, et al. Among authors: kaufmann sh. Cancer Res. 1997 Aug 15;57(16):3375-80. Cancer Res. 1997. PMID: 9269999

4

Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.

Bible KC, Boerner SA, Kirkland K, Anderl KL, Bartelt D Jr, Svingen PA, Kottke TJ, Lee YK, Eckdahl S, Stalboerger PG, Jenkins RB, Kaufmann SH. Bible KC, et al. Among authors: kaufmann sh. Clin Cancer Res. 2000 Feb;6(2):661-70. Clin Cancer Res. 2000. PMID: 10690552

5

A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.

Adjei AA, Erlichman C, Davis JN, Cutler DL, Sloan JA, Marks RS, Hanson LJ, Svingen PA, Atherton P, Bishop WR, Kirschmeier P, Kaufmann SH. Adjei AA, et al. Among authors: kaufmann sh. Cancer Res. 2000 Apr 1;60(7):1871-7. Cancer Res. 2000. PMID: 10766174 Clinical Trial.

6

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

Erlichman C, Boerner SA, Hallgren CG, Spieker R, Wang XY, James CD, Scheffer GL, Maliepaard M, Ross DD, Bible KC, Kaufmann SH. Erlichman C, et al. Among authors: kaufmann sh. Cancer Res. 2001 Jan 15;61(2):739-48. Cancer Res. 2001. PMID: 11212277

7

Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.

Shridhar V, Bible KC, Staub J, Avula R, Lee YK, Kalli K, Huang H, Hartmann LC, Kaufmann SH, Smith DI. Shridhar V, et al. Among authors: kaufmann sh. Cancer Res. 2001 May 15;61(10):4258-65. Cancer Res. 2001. PMID: 11358853

8

Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism.

Yoon JH, Werneburg NW, Higuchi H, Canbay AE, Kaufmann SH, Akgul C, Edwards SW, Gores GJ. Yoon JH, et al. Among authors: kaufmann sh. Cancer Res. 2002 Nov 15;62(22):6500-5. Cancer Res. 2002. PMID: 12438243

9

Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.

Lai J, Chien J, Staub J, Avula R, Greene EL, Matthews TA, Smith DI, Kaufmann SH, Roberts LR, Shridhar V. Lai J, et al. Among authors: kaufmann sh. J Biol Chem. 2003 Jun 20;278(25):23107-17. doi: 10.1074/jbc.M302203200. Epub 2003 Apr 9. J Biol Chem. 2003. PMID: 12686563 Free article.

10

A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer.

Chien J, Staub J, Hu SI, Erickson-Johnson MR, Couch FJ, Smith DI, Crowl RM, Kaufmann SH, Shridhar V. Chien J, et al. Among authors: kaufmann sh. Oncogene. 2004 Feb 26;23(8):1636-44. doi: 10.1038/sj.onc.1207271. Oncogene. 2004. PMID: 14716297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,206 results

Search Page

Filters